Alpha Cognition Total Current Assets 2020-2024 | ACOG
Alpha Cognition total current assets from 2020 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Alpha Cognition Annual Total Current Assets
(Millions of US $) |
| 2023 |
$2 |
| 2022 |
$2 |
| 2021 |
$12 |
| 2020 |
$8 |
| 2019 |
$6 |
Alpha Cognition Quarterly Total Current Assets
(Millions of US $) |
| 2024-06-30 |
$2 |
| 2024-03-31 |
$3 |
| 2023-12-31 |
$2 |
| 2023-09-30 |
$1 |
| 2023-06-30 |
$1 |
| 2023-03-31 |
$4 |
| 2022-12-31 |
$2 |
| 2022-09-30 |
$4 |
| 2022-06-30 |
$6 |
| 2022-03-31 |
$10 |
| 2021-12-31 |
$12 |
| 2021-09-30 |
$6 |
| 2021-06-30 |
$6 |
| 2021-03-31 |
$7 |
| 2020-12-31 |
$8 |
| 2020-09-30 |
|
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
$6 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
